← Elanco Animal Health Inc
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9b |
$3.1b
+6.15%
|
$3.1b
+0.14%
|
$3.3b
+6.59%
|
$4.8b
+45.57%
|
$4.4b
-7.43%
|
$4.4b
+0.14%
|
$4.4b
+0.50%
|
$4.7b
+6.22%
|
$5.0b
+6.47%
|
|
| Cost of sales | $1.5b |
$1.6b
+5.35%
|
$1.5b
-6.58%
|
$1.7b
+13.35%
|
$2.1b
+28.05%
|
$1.9b
-10.36%
|
$1.9b
+0.94%
|
$2.0b
+3.73%
|
$2.1b
+5.94%
|
$2.2b
+5.61%
|
|
| Gross Profit | $1.4b |
$1.5b
+7.02%
|
$1.6b
+7.21%
|
$1.6b
+0.37%
|
$2.6b
+63.75%
|
$2.5b
-5.06%
|
$2.5b
-0.48%
|
$2.4b
-2.01%
|
$2.6b
+6.44%
|
$2.8b
+7.17%
|
|
| Research and development | $251.7m | $246.6m | $270.1m | $327.0m | $369.0m | $321.0m | $327.0m | $344.0m | $368.0m | $371.0m | |
| Amortization of intangible assets | $221.2m | $197.4m | $200.4m | $359.9m | $556.0m | $528.0m | $548.0m | $527.0m | $543.0m | — | |
| Asset impairment, restructuring and other special charges | $375.1m | $128.8m | $185.5m | $623.7m | $628.0m | $183.0m | $127.0m | $150.0m | $237.0m | $20.0m | |
| Interest expense, net of capitalized interest | $0 | $29.6m | $78.9m | $149.8m | $236.0m | $241.0m | $277.0m | $235.0m | $220.0m | $248.0m | |
| Other expense, net | — | — | $28.0m | ($178.0m) | $5.0m | $32.0m | $75.0m | $18.0m | $19.0m | — | |
| (Loss) income before income taxes | ($232.6m) | $114.1m | $78.2m | ($672.0m) | ($567.0m) | ($72.0m) | ($1.2b) | $488.0m | ($224.0m) | — | |
| Income tax expense | $78.1m | $27.6m | $10.3m | ($111.9m) | ($95.0m) | $6.0m | $36.0m | $150.0m | $8.0m | $33.0m | |
| Basic (usd per share) | ($1.06) | $0.28 | $0.18 | ($1.27) | ($0.97) | ($0.16) | ($2.50) | $0.68 | ($0.47) | — | |
| Diluted (usd per share) | ($1.06) | $0.28 | $0.18 | ($1.27) | ($0.97) | ($0.16) | ($2.50) | $0.68 | ($0.47) | — | |
| Marketing, selling and administrative | $779.8m | $735.2m | $760.2m | $996.6m | $1.4b | $1.3b | $1.3b | $1.3b | $1.4b | — | |
| Goodwill impairment | — | — | — | — | $0 | $0 | $1.0b | $0 | $0 | $20.0m | |
| Gain on divestiture | — | — | — | — | — | $0 | $0 | ($640.0m) | $0 | — | |
| Net (loss) income | ($310.7m) | $86.5m | $67.9m | ($560.1m) | ($472.0m) | ($78.0m) | ($1.2b) | $338.0m | ($232.0m) | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.